Navigating the High Unmet Need and Changing Demographic Structure Driving the India Overactive Bladder (OAB) Treatment Market
The India Overactive Bladder (OAB) Treatment Market is poised for substantial growth, driven primarily by the country’s vast, rapidly urbanizing, and aging population, and the significant, yet often underdiagnosed, prevalence of OAB syndrome. OAB, a chronic condition characterized by urinary urgency, frequency, and nocturia, affects a large proportion of the elderly and diabetic population, which forms the core demand base discussed in the first paragraph. Increasing healthcare expenditure and growing patient awareness, particularly in urban and semi-urban centers, are slowly overcoming the cultural stigma and embarrassment associated with urinary incontinence and bladder issues, encouraging more patients to seek professional medical help from urologists and gynecologists. The market is currently dominated by pharmacological treatments, mainly comprising older-generation Anticholinergics (antimuscarinics) and, increasingly, newer Beta-3 Adrenergic Agonists like Mirabegron. The market for Anticholinergics remains robust due…